Preoperative Anticoagulation Management in Everyday Clinical Practice: An International Comparative Analysis of Work-as-Done Using the Functional Resonance Analysis Method.
Journal
Journal of patient safety
ISSN: 1549-8425
Titre abrégé: J Patient Saf
Pays: United States
ID NLM: 101233393
Informations de publication
Date de publication:
01 04 2021
01 04 2021
Historique:
pubmed:
12
7
2018
medline:
25
11
2021
entrez:
12
7
2018
Statut:
ppublish
Résumé
Preoperative anticoagulation management (PAM) is a complex, multidisciplinary process important to patient safety. The Functional Resonance Analysis Method (FRAM) is a novel method to study how complex processes usually go right at the frontline (labeled Safety-II) and how this relates to predefined procedures. This study aimed to assess PAM in everyday practice and explore the usability and utility of FRAM. The study was conducted at an Australian and European Cardiothoracic Surgery Department. A FRAM model of work-as-imagined was developed using (inter)national guidelines. Semistructured interviews with 18 involved professionals were used to develop models reflecting work-as-done at both sites, which were presented to staff for validation. Workload in hours was estimated per process step. In both centers, work-as-done differed from work-as-imagined, such as in the division of tasks among disciplines (e.g., nurses/registrars rather than medical specialists), but control mechanisms had been developed locally to ensure safe care (e.g., crosschecking with other clinicians). Centers had organized the process differently, revealing opportunities for improvement regarding patient information and clustering of clinic visits. Presenting FRAM models to staff initiated discussion on improvement of functions in the model that are vital for success. Overall workload was estimated at 47 hours per site. This FRAM analysis provided insight into PAM from the perspective of frontline clinicians, revealing essential functions, interdependencies and variability, and the relation with guidelines. Future studies are warranted to study the potential of FRAM, such as for guiding improvements in complex systems.
Identifiants
pubmed: 29994818
pii: 01209203-202104000-00001
doi: 10.1097/PTS.0000000000000515
doi:
Substances chimiques
Anticoagulants
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
157-165Informations de copyright
Copyright © 2018 Wolters Kluwer Health, Inc. All rights reserved.
Déclaration de conflit d'intérêts
The authors disclose no conflict of interest.
Références
Wysowski DK, Nourjah P, Swartz L. Bleeding complications with warfarin use a prevalent adverse effect resulting in regulatory action. Arch Intern Med . 2007;167:1414–1419.
Gomes T, Mamdani MM, Holbrook AM, et al. Rates of hemorrhage during warfarin therapy for atrial fibrillation. CMAJ . 2013;185:E121–E127.
Bates DW, Cullen DJ, Laird N, et al. Incidence of adverse drug events and potential adverse drug events. implications for prevention. ADE Prevention Study Group. JAMA . 1995;274:29–34.
Budnitz DS, Lovegrove MC, Shehab N, et al. Emergency hospitalizations for adverse drug events in older Americans. N Engl J Med . 2011;365:2002–2012.
Hakkarainen KM, Gyllensten H, Jönsson AK, et al. Prevalence, nature and potential preventability of adverse drug events - a population-based medical record study of 4970 adults. Br J Clin Pharmacol . 2014;78:170–183.
Damen NL, Baines R, Wagner C, et al. Medication-related adverse events during hospitalization: a retrospective patient record review study in The Netherlands. Pharmacoepidemiol Drug Saf . 2017;26:32–39.
Nielsen VG, Asmis LM. Hypercoagulability in the perioperative period. Best Pract Res Clin Anaesthesiol . 2010;24:133–144.
Wysokinski WE, McBane RD. Periprocedural bridging management of anticoagulation. Circulation . 2012;126:486–490.
Flaker GC, Theriot P, Binder LG, et al. Management of periprocedural anticoagulation: a survey of contemporary practice. J Am Coll Cardiol . 2016;68:217–226.
NHS Herts Valleys Commissioning Group. Hertfordshire guidelines for oral anticoagulation of patients with non-valvular AF. UK: 2016. UK . 2016. Available at: http://hertsvalleysccg.nhs.uk/publications/pharmacy-and-medicines-optimisation/local-decisions/cardiovascular-system/anticoagulants/3206-af-treatment-guideline-long-december-2015/file . Accessed January 29, 2018.
Dutch Health Care Inspectorate. Anticoagulant Care Chain Not Sufficiently Sound (Dutch). The Hague, the Netherlands; 2010. Available at: http://www.sin-nl.org/pdfs/igz_rapport_keten_trombosezorg_niet_sluitend_okt._2010.pdf . Accessed January 29, 2018.
Kirchhof P, Benussi S, Kotecha D, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS: the task force on myocardial revascularization of the European Society of Cardiology (ESC) developed with the special contribution of the European Heart R. Eur Hear J . 2016;37:2893–2962.
You J, Singer D, Howard P, et al. Antithrombotic therapy for atrial fibrillation: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest . 2012;141:e531S–e575S.
Heidbuchel H, Verhamme P, Alings M, et al. Updated European Heart Rhythm Association practical guide on the use of non-vitamin-K antagonist anticoagulants in patients with non-valvular atrial fibrillation: executive summary. Eur Heart J . 2017;38:2137–2149.
Keeling D, Tait RC, Watson H. British Committee of Standards for Haematology. Peri-operative management of anticoagulation and antiplatelet therapy. Br J Haematol . 2016;175:602–613.
Nishimura RA, Otto CM, Bonow RO, et al.; American College of Cardiology; American College of Cardiology/American Heart Association; American Heart Association. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Thorac Cardiovasc Surg . 2014;148:e1–e132.
Tompkins C, Cheng A, Dalal D, et al. Dual antiplatelet therapy and heparin “bridging” significantly increase the risk of bleeding complications after pacemaker or implantable cardioverter-defibrillator device implantation. J Am Coll Cardiol . 2010;55:2376–2382.
Eijgenraam P, ten Cate H, ten Cate-Hoek AT. Practice of bridging anticoagulation: guideline adherence and risk factors for bleeding. Neth J Med . 2014;72:157–164.
Steinberg BA, Kim S, Thomas L, et al.; Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) Investigators and Patients. Lack of concordance between empirical scores and physician assessments of stroke and bleeding risk in atrial fibrillation: results from the outcomes registry for better informed treatment of atrial fibrillation (ORBIT-AF) registry. Circulation . 2014;129:2005–2012.
Damen N, Damen P, van Dijk L, et al. Implementation of the National Standard Anticoagulation Chain (V2.0): Current State of Affairs (Dutch). Utrecht, the Netherlands; 2015. Available at: https://www.nivel.nl/sites/default/files/bestanden/Rapport-quickscan-implementatie-LSKA.pdf ? Accessed January 29, 2018.
Hollnagel E. Safety-I and Safety-II. The Past and Future of Safety Management . Farnham, UK: Ashgate Publishing Limited; 2014.
Lawton R, Taylor N, Clay-Williams R, et al. Positive deviance: a different approach to achieving patient safety. BMJ Qual Saf . 2014;23:880–883.
Baxter R, Taylor N, Kellar I, et al. What methods are used to apply positive deviance within healthcare organisations? A systematic review. BMJ Qual Saf . 2016;25:190–201.
Scerri A, Innes A, Scerri C. Discovering what works well: exploring quality dementia care in hospital wards using an appreciative inquiry approach. J Clin Nurs . 2015;24:1916–1925.
Kelly N, Blake S, Plunkett A. Learning from excellence in healthcare: a new approach to incident reporting. Arch Dis Child . 2016;101:788–791.
Hollnagel E, Wears R, Braithwaite J. From Safety-I to Safety-II: A White Paper. Published simultaneously by the University of Southern Denmark, University of Florida, USA, and Macquarie University, Australia; 2015. Available at: http://resilienthealthcare.net/onewebmedia/WhitePaperFinal.pdf . Accessed January 29, 2018.
Braithwaite J, Wears RL, Hollnagel E. Resilient health care: turning patient safety on its head. Int J Qual Health Care . 2015;27:418–420.
Hollnagel E, Braithwaite J, Wears RL. Resilient Health Care . Farnham, England: Ashgate Publishing Limited; 2015.
Grol R, Wensing M. Effective implementation of change in healthcare: a systematic approach. In: Grol R, Wensing M, Eccles M, Davis D, eds. Improving Patient Care: The Implementation of Change in Health Care . Oxford, UK: John Wiley & Sons, Ltd, 2013:40–63.
Hollnagel E. FRAM: The Functional Resonance Analysis Method. Modelling Complex Socio-Technical Systems . Surrey, UK: Ashgate Publishing Limited; 2012.
Nouvel D, Travadel S, Hollnagel E. Introduction of the concept of functional resonance in the analysis of a near-accident in aviation. Introduction of the concept of functional resonance in the analysis of a near-accident in aviation. 33rd ESReDA Seminar: future challenges of accident inv. In: 33rd ESReDA Seminar: Future Challenges of Accident Invesitgation . Ispra, Italy, 2007. Available at: https://hal-mines-paristech.archives-ouvertes.fr/hal-00614258/document . Accessed January 29, 2018.
Woltjer R. Functional modeling of constraint management in aviation safety and command and control [Doctoral thesis]. 2009. Available at: http://liu.diva-portal.org/smash/get/diva2:210824/FULLTEXT01.pdf . Accessed August 22, 2017.
De Carvalho PVR. The use of Functional Resonance Analysis Method (FRAM) in a mid-air collision to understand some characteristics of the air traffic management system resilience. Reliab Eng Syst Saf . 2011;96:1482–1498.
Belmonte F, Schön W, Heurley L, et al. Interdisciplinary safety analysis of complex socio-technological systems based on the Functional Resonance Accident Model: an application to railway traffic supervision. Reliab Eng Syst Saf . 2011;96:237–249.
Amorim AG, Pereira CMNA. Improvisation at workplace and accident causation - an exploratory study. Procedia Manuf . 2015;3:1804–1811.
Rosa L, Haddad A, de Carvalho P. Assessing risk in sustainable construction using the Functional Resonance Analysis Method (FRAM). Cogn Technol Work . 2015;17:559–573.
Clay-Williams R, Hounsgaard J, Hollnagel E. Where the rubber meets the road: using FRAM to align work-as-imagined with work-as-done when implementing clinical guidelines. Implement Sci . 2015;10:125.
Raben DC, Bogh SB, Viskum B, et al. Learn from what goes right: a demonstration of a new systematic method for identification of leading indicators in healthcare. Reliab Eng Syst Saf . 2018;169:187–198.
Hounsgaard J. Patient safety in everyday work. Learning from what goes right [MSc thesis]. University of Southern Denmark; 2016. Available at: http://functionalresonance.com/onewebmedia/Hounsgaard%20(2016).pdf . Accessed January 29, 2018.
Hollnagel E, Hounsgaard J. FRAM – The Functional Resonance Analysis Method – A Handbook for Practical Use of the Method. Middelfart, Denmark; 2014. Available at: http://functionalresonance.com/onewebmedia/FRAM_handbook_web-2.pdf . Accessed January 29, 2018.
Resilient Health Care Net Meeting. Available at: http://resilienthealthcare.net/meetings/index.html . Accessed August 23, 2017.
FRAMily meeting. Available at: http://functionalresonance.com/framily-meetings/index.html . Accessed January 29, 2018.
Douketis J, Spyropoulos A, Spencer F, et al. Perioperative Management of Antithrombotic Therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest . 2012;141:e326S–e350S.
Dutch National Steering Committee on Chain of Antithrombotics Care. Dutch National Standard Chain of Care on Antithrombotics – Version 2.0 (Dutch). Utrecht, the Netherlands; 2014. Available at: https://www.knmp.nl/patientenzorg/samenwerking/landelijke-standaard-keten-antistolling-2-0-lska . Accessed August 22, 2017.
Hill R. FRAM Model Visualiser. version 0.4.1. Available at: http://functionalresonance.com/the%20fram%20model%20visualiser.html . Accessed January 29, 2018.
Mason M. Sample Size and Saturation in PhD Studies Using Qualitative Interviews. Forum Qualitative Sozialforschung/Forum: Qualitative Social Research . 2010. Available at: http://www.qualitative-research.net/index.php/fqs/article/view/1428 . Published 2010. Accessed May 6, 2018.
Taitz J, Genn K, Brooks V, et al. System-wide learning from root cause analysis: a report from the New South Wales Root Cause Analysis Review Committee. Qual Saf Health Care . 2010;19:e63.
Hounsgaard J. Using FRAM as a Quality Improvement Tool in Health Care. In: The FRAMily Meeting . Munich, Germany: 2013. Available at: http://functionalresonance.com/onewebmedia/FRAMily_2013_Hounsgaard.pdf . Published 2013. Accessed May 6, 2018.
Patriarca R, Di Gravio G, Costantino F. A Monte Carlo evolution of the Functional Resonance Analysis Method (FRAM) to assess performance variability in complex systems. Saf Sci . 2017;91:49–60.
Feeley D. Six Resolutions to Reboot Patient Safety. Institute for Healthcare Improvement. Available at: http://www.ihi.org/communities/blogs/_layouts/15/ihi/community/blog/ItemView.aspx?List=7d1126ec-8f63-4a3b-9926-c44ea3036813&ID=365&Web=1e880535-d855-4727-a8c1-27ee672f115d . Published 2017. Accessed September 1, 2017.
Catchpole K, Neyens DM, Abernathy J, et al. Framework for direct observation of performance and safety in healthcare. BMJ Qual Saf . 2017;26:1015–1021.
Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care . 2007;19:349–357.